OS Therapies Advances Breakthrough Osteosarcoma Treatment Toward Approval
September 30, 2026 — OS Therapies reports 75% 2-year survival in osteosarcoma trial, plans regulatory filings for OST-HER2 with FDA and UK MHRA by year-end 2025.
NewsRamp provides syndicated and curated news distribution and marketing services for major newswires.
September 30, 2026 — OS Therapies reports 75% 2-year survival in osteosarcoma trial, plans regulatory filings for OST-HER2 with FDA and UK MHRA by year-end 2025.
September 30, 2026 — OS Therapies advances OST-HER2 immunotherapy for osteosarcoma with FDA RMAT designation. Phase 2b results show significant survival improvement. Potential 2026 launch with commercial partner Eversana.
May 31, 2026 — Cingulate advances CTx-1301 ADHD treatment with FDA acceptance and 2026 PDUFA date. Stonegate updates coverage as company prepares for potential commercial launch.
January 1, 2026 — BioUtah announces new board leadership with Erin Barry as chair and Andrew Hemmert as vice chair, plus three new board members. Changes take effect January 2026 for Utah's life sciences trade association.
December 12, 2025 — American Heart Association warns Arctic blast and snow shoveling increase heart attack risk. Learn safety tips to protect your heart during extreme cold weather.
December 12, 2025 — New study reveals rising rates of aggressive breast cancer in women under 40, challenging current screening guidelines and highlighting need for new therapeutic approaches.
December 12, 2025 — LogicMark launches AI-powered Activity Metrics that predicts senior health risks before emergencies occur. The technology transforms medical alerts from reactive to proactive care monitoring.
December 12, 2025 — Fudan University researchers create pH-responsive hydrogel that switches from antibacterial to tissue repair modes for infected wounds. Achieved 90% closure in 14 days in preclinical tests.
December 12, 2025 — Amelia Hernandez wins Bogin, Munns & Munns' 2025 FASD Scholarship for her advocacy inspired by family experience with the disorder, aiming to improve social work.
December 12, 2025 — Study reveals antimicrobial peptides as a breakthrough for oral diseases, offering low-resistance alternatives to antibiotics for cavities, gum disease, and cancer treatment.
December 11, 2025 — M1 Kliniken AG appoints Katharina Zimmnau to its Executive Board, strengthening leadership for growth in medical aesthetic services across Europe and Australia.
December 11, 2025 — NeuroOne Medical Technologies announces Q4 and fiscal 2025 financial results release on Dec 17, 2025, with investor call details. Learn about its neurology innovations.
December 11, 2025 — CEO Michael Jones leverages outsider perspective to transform disability support at Ability to Achieve, simplifying complex systems and achieving life-changing outcomes for NDIS participants across Sydney.
December 11, 2025 — Anne Therese Aesthetic Medicine opens a new med spa in Bonita Springs, FL, offering Botox, fillers, and skincare treatments under board-certified physician Dr. Anne Therese Stubbs.
December 11, 2025 — Laser Center of Marin in Corte Madera offers expert skincare treatments, including facials and laser procedures, with personalized care from licensed professionals. Learn more about their medical-grade services.
December 11, 2025 — Sigyn Therapeutics unveils CardioDialysis, a breakthrough device using dialysis infrastructure to treat cardiovascular disease with potential 75-95% MACE reduction in ESRD patients.
December 11, 2025 — VolitionRx announces Capture-Seq™, a new liquid biopsy method achieving 100% accuracy in early cancer detection via enriched DNA fragment analysis in blood samples.
December 11, 2025 — Wearable Devices receives $750K from Israel Innovation Authority for clinical pilot using Mudra Link neural wristband for rehabilitation at Soroka Medical Center.
December 11, 2025 — TransCode Therapeutics partners with Quantum Leap to test TTX-MC138 in a Phase 2a trial for colorectal cancer patients at high risk of recurrence, targeting minimal residual disease.
December 11, 2025 — Experts reveal how to restore plummeting public trust in U.S. healthcare post-pandemic, with insights on Astiva Health and BioMedWire's role in communications.